nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—Propylthiouracil—Graves' disease	0.748	1	CbGbCtD
Mesalazine—Lupus-like syndrome—Methimazole—Graves' disease	0.0119	0.0898	CcSEcCtD
Mesalazine—Lupus-like syndrome—Propylthiouracil—Graves' disease	0.0101	0.0763	CcSEcCtD
Mesalazine—Drug fever—Methimazole—Graves' disease	0.00841	0.0634	CcSEcCtD
Mesalazine—Nephritis—Methimazole—Graves' disease	0.00822	0.0619	CcSEcCtD
Mesalazine—Drug fever—Propylthiouracil—Graves' disease	0.00715	0.0539	CcSEcCtD
Mesalazine—Nephritis—Propylthiouracil—Graves' disease	0.00699	0.0527	CcSEcCtD
Mesalazine—Erythema nodosum—Propylthiouracil—Graves' disease	0.00552	0.0416	CcSEcCtD
Mesalazine—Lung infiltration—Propylthiouracil—Graves' disease	0.00509	0.0384	CcSEcCtD
Mesalazine—Interstitial pneumonia—Propylthiouracil—Graves' disease	0.00494	0.0372	CcSEcCtD
Mesalazine—CHUK—connective tissue—Graves' disease	0.00385	0.11	CbGeAlD
Mesalazine—Olsalazine—IFNG—Graves' disease	0.00375	1	CrCbGaD
Mesalazine—Interstitial lung disease—Propylthiouracil—Graves' disease	0.00337	0.0254	CcSEcCtD
Mesalazine—CHUK—adipose tissue—Graves' disease	0.00295	0.0841	CbGeAlD
Mesalazine—Liver injury—Propylthiouracil—Graves' disease	0.00284	0.0214	CcSEcCtD
Mesalazine—Aplastic anaemia—Methimazole—Graves' disease	0.00264	0.0199	CcSEcCtD
Mesalazine—IKBKB—connective tissue—Graves' disease	0.00262	0.0745	CbGeAlD
Mesalazine—CHUK—thyroid gland—Graves' disease	0.00256	0.0728	CbGeAlD
Mesalazine—Lymphadenopathy—Methimazole—Graves' disease	0.00239	0.018	CcSEcCtD
Mesalazine—Aplastic anaemia—Propylthiouracil—Graves' disease	0.00224	0.0169	CcSEcCtD
Mesalazine—ALOX5—connective tissue—Graves' disease	0.00217	0.0618	CbGeAlD
Mesalazine—Lymphadenopathy—Propylthiouracil—Graves' disease	0.00203	0.0153	CcSEcCtD
Mesalazine—IKBKB—pituitary gland—Graves' disease	0.00201	0.0574	CbGeAlD
Mesalazine—IKBKB—adipose tissue—Graves' disease	0.00201	0.0572	CbGeAlD
Mesalazine—Hepatic failure—Propylthiouracil—Graves' disease	0.00193	0.0145	CcSEcCtD
Mesalazine—Renal failure acute—Propylthiouracil—Graves' disease	0.00188	0.0141	CcSEcCtD
Mesalazine—MPO—connective tissue—Graves' disease	0.00183	0.0523	CbGeAlD
Mesalazine—IKBKB—thyroid gland—Graves' disease	0.00174	0.0495	CbGeAlD
Mesalazine—ALOX5—adipose tissue—Graves' disease	0.00166	0.0474	CbGeAlD
Mesalazine—PPARG—connective tissue—Graves' disease	0.00163	0.0464	CbGeAlD
Mesalazine—Neuropathy peripheral—Methimazole—Graves' disease	0.00154	0.0116	CcSEcCtD
Mesalazine—Jaundice—Methimazole—Graves' disease	0.00153	0.0115	CcSEcCtD
Mesalazine—Agranulocytosis—Methimazole—Graves' disease	0.00147	0.011	CcSEcCtD
Mesalazine—ALOX5—thyroid gland—Graves' disease	0.00144	0.041	CbGeAlD
Mesalazine—MPO—pituitary gland—Graves' disease	0.00141	0.0403	CbGeAlD
Mesalazine—Hepatitis—Methimazole—Graves' disease	0.00141	0.0106	CcSEcCtD
Mesalazine—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00131	0.00986	CcSEcCtD
Mesalazine—Jaundice—Propylthiouracil—Graves' disease	0.0013	0.00981	CcSEcCtD
Mesalazine—PPARG—adipose tissue—Graves' disease	0.00125	0.0356	CbGeAlD
Mesalazine—Agranulocytosis—Propylthiouracil—Graves' disease	0.00125	0.00939	CcSEcCtD
Mesalazine—Alopecia—Methimazole—Graves' disease	0.00125	0.00939	CcSEcCtD
Mesalazine—Haemoglobin—Propylthiouracil—Graves' disease	0.00121	0.00908	CcSEcCtD
Mesalazine—Hepatitis—Propylthiouracil—Graves' disease	0.0012	0.00903	CcSEcCtD
Mesalazine—Haemorrhage—Propylthiouracil—Graves' disease	0.0012	0.00903	CcSEcCtD
Mesalazine—Vertigo—Methimazole—Graves' disease	0.0011	0.00831	CcSEcCtD
Mesalazine—Leukopenia—Methimazole—Graves' disease	0.0011	0.00828	CcSEcCtD
Mesalazine—PPARG—thyroid gland—Graves' disease	0.00108	0.0308	CbGeAlD
Mesalazine—Alopecia—Propylthiouracil—Graves' disease	0.00106	0.00798	CcSEcCtD
Mesalazine—Arthralgia—Methimazole—Graves' disease	0.00105	0.00787	CcSEcCtD
Mesalazine—Myalgia—Methimazole—Graves' disease	0.00105	0.00787	CcSEcCtD
Mesalazine—Dysgeusia—Propylthiouracil—Graves' disease	0.00102	0.0077	CcSEcCtD
Mesalazine—Oedema—Methimazole—Graves' disease	0.001	0.00755	CcSEcCtD
Mesalazine—Thrombocytopenia—Methimazole—Graves' disease	0.000981	0.00739	CcSEcCtD
Mesalazine—Vertigo—Propylthiouracil—Graves' disease	0.000938	0.00707	CcSEcCtD
Mesalazine—Leukopenia—Propylthiouracil—Graves' disease	0.000934	0.00704	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Methimazole—Graves' disease	0.000913	0.00688	CcSEcCtD
Mesalazine—Paraesthesia—Methimazole—Graves' disease	0.0009	0.00678	CcSEcCtD
Mesalazine—Somnolence—Methimazole—Graves' disease	0.000891	0.00671	CcSEcCtD
Mesalazine—Arthralgia—Propylthiouracil—Graves' disease	0.000889	0.00669	CcSEcCtD
Mesalazine—Myalgia—Propylthiouracil—Graves' disease	0.000889	0.00669	CcSEcCtD
Mesalazine—Dyspepsia—Methimazole—Graves' disease	0.000882	0.00664	CcSEcCtD
Mesalazine—PTGS1—connective tissue—Graves' disease	0.00087	0.0248	CbGeAlD
Mesalazine—Oedema—Propylthiouracil—Graves' disease	0.000852	0.00642	CcSEcCtD
Mesalazine—Thrombocytopenia—Propylthiouracil—Graves' disease	0.000834	0.00628	CcSEcCtD
Mesalazine—PTGS2—connective tissue—Graves' disease	0.000832	0.0237	CbGeAlD
Mesalazine—Urticaria—Methimazole—Graves' disease	0.000796	0.006	CcSEcCtD
Mesalazine—Body temperature increased—Methimazole—Graves' disease	0.000792	0.00597	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.000776	0.00585	CcSEcCtD
Mesalazine—Paraesthesia—Propylthiouracil—Graves' disease	0.000765	0.00576	CcSEcCtD
Mesalazine—Somnolence—Propylthiouracil—Graves' disease	0.000757	0.00571	CcSEcCtD
Mesalazine—Dyspepsia—Propylthiouracil—Graves' disease	0.00075	0.00565	CcSEcCtD
Mesalazine—Pruritus—Methimazole—Graves' disease	0.000709	0.00534	CcSEcCtD
Mesalazine—Urticaria—Propylthiouracil—Graves' disease	0.000677	0.0051	CcSEcCtD
Mesalazine—Body temperature increased—Propylthiouracil—Graves' disease	0.000674	0.00507	CcSEcCtD
Mesalazine—PTGS1—pituitary gland—Graves' disease	0.00067	0.0191	CbGeAlD
Mesalazine—PTGS1—adipose tissue—Graves' disease	0.000667	0.019	CbGeAlD
Mesalazine—PTGS2—pituitary gland—Graves' disease	0.000641	0.0183	CbGeAlD
Mesalazine—PTGS2—adipose tissue—Graves' disease	0.000638	0.0182	CbGeAlD
Mesalazine—Vomiting—Methimazole—Graves' disease	0.000637	0.0048	CcSEcCtD
Mesalazine—Rash—Methimazole—Graves' disease	0.000632	0.00476	CcSEcCtD
Mesalazine—Dermatitis—Methimazole—Graves' disease	0.000631	0.00475	CcSEcCtD
Mesalazine—Headache—Methimazole—Graves' disease	0.000628	0.00473	CcSEcCtD
Mesalazine—Pruritus—Propylthiouracil—Graves' disease	0.000603	0.00454	CcSEcCtD
Mesalazine—Nausea—Methimazole—Graves' disease	0.000595	0.00448	CcSEcCtD
Mesalazine—PTGS1—thyroid gland—Graves' disease	0.000578	0.0165	CbGeAlD
Mesalazine—Vomiting—Propylthiouracil—Graves' disease	0.000542	0.00408	CcSEcCtD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.00054	0.0067	CbGpPWpGaD
Mesalazine—CHUK—FoxO family signaling—FASLG—Graves' disease	0.000538	0.00667	CbGpPWpGaD
Mesalazine—Rash—Propylthiouracil—Graves' disease	0.000537	0.00405	CcSEcCtD
Mesalazine—CHUK—TCR signaling in naïve CD8+ T cells—CD8A—Graves' disease	0.000537	0.00666	CbGpPWpGaD
Mesalazine—CHUK—Downstream TCR signaling—HLA-DRB1—Graves' disease	0.000537	0.00666	CbGpPWpGaD
Mesalazine—Dermatitis—Propylthiouracil—Graves' disease	0.000537	0.00404	CcSEcCtD
Mesalazine—MPO—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000536	0.00665	CbGpPWpGaD
Mesalazine—Headache—Propylthiouracil—Graves' disease	0.000534	0.00402	CcSEcCtD
Mesalazine—CHUK—TCR signaling—HLA-DQB1—Graves' disease	0.000528	0.00655	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—ICAM1—Graves' disease	0.00051	0.00633	CbGpPWpGaD
Mesalazine—Nausea—Propylthiouracil—Graves' disease	0.000506	0.00381	CcSEcCtD
Mesalazine—MPO—IL23-mediated signaling events—TNF—Graves' disease	0.000503	0.00624	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—IFNG—Graves' disease	0.000489	0.00606	CbGpPWpGaD
Mesalazine—IKBKB—FoxO family signaling—FASLG—Graves' disease	0.000488	0.00605	CbGpPWpGaD
Mesalazine—CHUK—Interleukin-11 Signaling Pathway—ICAM1—Graves' disease	0.000487	0.00605	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD8+ T cells—CD8A—Graves' disease	0.000487	0.00604	CbGpPWpGaD
Mesalazine—IKBKB—Downstream TCR signaling—HLA-DRB1—Graves' disease	0.000487	0.00604	CbGpPWpGaD
Mesalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.000485	0.00601	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000482	0.00597	CbGpPWpGaD
Mesalazine—CHUK—Validated transcriptional targets of TAp63 isoforms—FAS—Graves' disease	0.00048	0.00595	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD8+ T cells—HLA-A—Graves' disease	0.000479	0.00594	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling—HLA-DQB1—Graves' disease	0.000479	0.00594	CbGpPWpGaD
Mesalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.000465	0.00576	CbGpPWpGaD
Mesalazine—PPARG—Transcription factor regulation in adipogenesis—TNF—Graves' disease	0.000445	0.00552	CbGpPWpGaD
Mesalazine—IKBKB—Interleukin-11 Signaling Pathway—ICAM1—Graves' disease	0.000442	0.00548	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—IL1B—Graves' disease	0.000436	0.00541	CbGpPWpGaD
Mesalazine—IKBKB—Validated transcriptional targets of TAp63 isoforms—FAS—Graves' disease	0.000435	0.0054	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD8+ T cells—HLA-A—Graves' disease	0.000434	0.00539	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.000434	0.00538	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.00042	0.00521	CbGpPWpGaD
Mesalazine—CHUK—RANKL/RANK Signaling Pathway—ICAM1—Graves' disease	0.000408	0.00506	CbGpPWpGaD
Mesalazine—CHUK—IL1-mediated signaling events—IL1B—Graves' disease	0.000406	0.00504	CbGpPWpGaD
Mesalazine—CHUK—Canonical NF-kappaB pathway—TNF—Graves' disease	0.000403	0.005	CbGpPWpGaD
Mesalazine—CHUK—EBV LMP1 signaling—TNF—Graves' disease	0.000403	0.005	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000402	0.00499	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling—HLA-DRB1—Graves' disease	0.000401	0.00498	CbGpPWpGaD
Mesalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.000389	0.00483	CbGpPWpGaD
Mesalazine—MPO—C-MYB transcription factor network—CD4—Graves' disease	0.000389	0.00483	CbGpPWpGaD
Mesalazine—MPO—Vitamin B12 Metabolism—TNF—Graves' disease	0.000389	0.00482	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—IFNG—Graves' disease	0.000388	0.00482	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.000381	0.00472	CbGpPWpGaD
Mesalazine—CHUK—Downstream TCR signaling—CD4—Graves' disease	0.000379	0.0047	CbGpPWpGaD
Mesalazine—IKBKB—Type II diabetes mellitus—TNF—Graves' disease	0.000379	0.0047	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.000375	0.00466	CbGpPWpGaD
Mesalazine—IKBKB—RANKL/RANK Signaling Pathway—ICAM1—Graves' disease	0.00037	0.00459	CbGpPWpGaD
Mesalazine—IKBKB—IL1-mediated signaling events—IL1B—Graves' disease	0.000369	0.00457	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—HLA-DRB1—Graves' disease	0.000367	0.00455	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—IFNG—Graves' disease	0.000366	0.00455	CbGpPWpGaD
Mesalazine—IKBKB—EBV LMP1 signaling—TNF—Graves' disease	0.000366	0.00454	CbGpPWpGaD
Mesalazine—IKBKB—Canonical NF-kappaB pathway—TNF—Graves' disease	0.000366	0.00454	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling—HLA-DRB1—Graves' disease	0.000364	0.00452	CbGpPWpGaD
Mesalazine—CHUK—Interleukin-1 signaling—IL1B—Graves' disease	0.000357	0.00443	CbGpPWpGaD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000356	0.00442	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—CD8A—Graves' disease	0.000352	0.00436	CbGpPWpGaD
Mesalazine—PTGS1—Overview of nanoparticle effects—TNF—Graves' disease	0.000351	0.00435	CbGpPWpGaD
Mesalazine—CHUK—NOD pathway—IL1B—Graves' disease	0.00035	0.00434	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—FASLG—Graves' disease	0.000349	0.00434	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—IL1B—Graves' disease	0.000346	0.0043	CbGpPWpGaD
Mesalazine—IKBKB—Downstream TCR signaling—CD4—Graves' disease	0.000344	0.00426	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.00034	0.00422	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—FAS—Graves' disease	0.000337	0.00418	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—HLA-DRB1—Graves' disease	0.000333	0.00413	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.000328	0.00407	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—IL1B—Graves' disease	0.000327	0.00406	CbGpPWpGaD
Mesalazine—IKBKB—Interleukin-1 signaling—IL1B—Graves' disease	0.000324	0.00402	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—CD8A—Graves' disease	0.000319	0.00396	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—FAS—Graves' disease	0.000319	0.00396	CbGpPWpGaD
Mesalazine—IKBKB—NOD pathway—IL1B—Graves' disease	0.000317	0.00394	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—FASLG—Graves' disease	0.000317	0.00393	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—TNF—Graves' disease	0.000316	0.00392	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000313	0.00389	CbGpPWpGaD
Mesalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.000307	0.0038	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—FAS—Graves' disease	0.000305	0.00379	CbGpPWpGaD
Mesalazine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Graves' disease	0.000302	0.00375	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.0003	0.00373	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.000297	0.00369	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—FASLG—Graves' disease	0.000297	0.00369	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—HLA-E—Graves' disease	0.000294	0.00364	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.000293	0.00363	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—FAS—Graves' disease	0.000289	0.00359	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—FAS—Graves' disease	0.000287	0.00356	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling—CD4—Graves' disease	0.000283	0.00351	CbGpPWpGaD
Mesalazine—PTGS2—Overview of nanoparticle effects—TNF—Graves' disease	0.000278	0.00345	CbGpPWpGaD
Mesalazine—CHUK—IL-1 signaling pathway—IL1B—Graves' disease	0.000277	0.00343	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—HLA-E—Graves' disease	0.000276	0.00343	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—IL2RA—Graves' disease	0.000274	0.0034	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.000266	0.0033	CbGpPWpGaD
Mesalazine—CHUK—TCR signaling in naïve CD4+ T cells—CD4—Graves' disease	0.000259	0.00321	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling—CD4—Graves' disease	0.000257	0.00319	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—FAS—Graves' disease	0.000253	0.00314	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—TNF—Graves' disease	0.000251	0.00312	CbGpPWpGaD
Mesalazine—IKBKB—IL-1 signaling pathway—IL1B—Graves' disease	0.000251	0.00311	CbGpPWpGaD
Mesalazine—CHUK—TWEAK Signaling Pathway—TNF—Graves' disease	0.000249	0.00309	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000249	0.00309	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL2RA—Graves' disease	0.000248	0.00308	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—TNF—Graves' disease	0.000237	0.00294	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—Graves' disease	0.000235	0.00291	CbGpPWpGaD
Mesalazine—CHUK—TNF receptor signaling pathway —TNF—Graves' disease	0.000232	0.00287	CbGpPWpGaD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000231	0.00286	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—TNF—Graves' disease	0.000226	0.0028	CbGpPWpGaD
Mesalazine—CHUK—Leptin signaling pathway—IL1B—Graves' disease	0.000216	0.00268	CbGpPWpGaD
Mesalazine—IKBKB—TNF receptor signaling pathway —TNF—Graves' disease	0.00021	0.00261	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000209	0.00259	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—CD4—Graves' disease	0.000202	0.00251	CbGpPWpGaD
Mesalazine—CHUK—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000201	0.00249	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000198	0.00246	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CXCL10—Graves' disease	0.000198	0.00245	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—HLA-B—Graves' disease	0.000197	0.00244	CbGpPWpGaD
Mesalazine—IKBKB—Leptin signaling pathway—IL1B—Graves' disease	0.000196	0.00243	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.000191	0.00238	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—IL1B—Graves' disease	0.000187	0.00231	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—CD4—Graves' disease	0.000183	0.00227	CbGpPWpGaD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—TNF—Graves' disease	0.000182	0.00226	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—FASLG—Graves' disease	0.000182	0.00226	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000181	0.00225	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GC—Graves' disease	0.000179	0.00222	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—FAS—Graves' disease	0.000179	0.00222	CbGpPWpGaD
Mesalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—Graves' disease	0.000176	0.00219	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—FAS—Graves' disease	0.000175	0.00218	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000175	0.00217	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000174	0.00216	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.000174	0.00215	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—IL1B—Graves' disease	0.000169	0.0021	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000169	0.00209	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000166	0.00206	CbGpPWpGaD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—Graves' disease	0.000163	0.00203	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—IL1B—Graves' disease	0.000161	0.002	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IFNG—Graves' disease	0.000159	0.00197	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000153	0.0019	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.000152	0.00188	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL1B—Graves' disease	0.000146	0.00181	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TNF—Graves' disease	0.000143	0.00177	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.000143	0.00177	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL1B—Graves' disease	0.000142	0.00176	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000138	0.00172	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.000138	0.00171	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000137	0.0017	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IFIH1—Graves' disease	0.000136	0.00169	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000136	0.00169	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—B3GNT2—Graves' disease	0.000136	0.00168	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000133	0.00165	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000132	0.00163	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—ICAM1—Graves' disease	0.000131	0.00163	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TNF—Graves' disease	0.00013	0.00161	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.00013	0.00161	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.000128	0.00159	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000128	0.00159	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CD4—Graves' disease	0.000126	0.00157	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000126	0.00157	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IFNG—Graves' disease	0.000126	0.00156	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IFIH1—Graves' disease	0.000124	0.00154	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.000124	0.00154	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000122	0.00152	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—TNF—Graves' disease	0.000121	0.0015	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.000119	0.00148	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000116	0.00144	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000115	0.00143	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000115	0.00142	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL1B—Graves' disease	0.000112	0.0014	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000111	0.00138	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GC—Graves' disease	0.000111	0.00138	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000111	0.00138	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—TNF—Graves' disease	0.000107	0.00133	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—HLA-E—Graves' disease	0.000107	0.00133	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000107	0.00133	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000105	0.0013	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000103	0.00128	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-E—Graves' disease	0.000103	0.00128	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—TNF—Graves' disease	0.000103	0.00128	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—IL1B—Graves' disease	0.000103	0.00127	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD40—Graves' disease	0.000101	0.00125	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000101	0.00125	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IFNG—Graves' disease	9.97e-05	0.00124	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CTLA4—Graves' disease	9.93e-05	0.00123	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—HLA-E—Graves' disease	9.74e-05	0.00121	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	9.56e-05	0.00119	CbGpPWpGaD
Mesalazine—CHUK—Disease—B3GNT2—Graves' disease	9.42e-05	0.00117	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-E—Graves' disease	9.35e-05	0.00116	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD40—Graves' disease	9.14e-05	0.00113	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CTLA4—Graves' disease	9.01e-05	0.00112	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL1B—Graves' disease	8.9e-05	0.0011	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	8.67e-05	0.00108	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IFNG—Graves' disease	8.43e-05	0.00105	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—B3GNT2—Graves' disease	8.4e-05	0.00104	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-DQB1—Graves' disease	8.18e-05	0.00101	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—Graves' disease	8.16e-05	0.00101	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFIH1—Graves' disease	7.95e-05	0.000986	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GC—Graves' disease	7.77e-05	0.000964	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—HLA-B—Graves' disease	7.65e-05	0.000949	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IFNG—Graves' disease	7.65e-05	0.000949	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD8A—Graves' disease	7.64e-05	0.000948	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL1B—Graves' disease	7.52e-05	0.000934	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—Graves' disease	7.45e-05	0.000924	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-DQB1—Graves' disease	7.42e-05	0.00092	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	7.41e-05	0.00092	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-B—Graves' disease	7.35e-05	0.000912	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFIH1—Graves' disease	7.21e-05	0.000894	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—HLA-B—Graves' disease	6.94e-05	0.000861	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD8A—Graves' disease	6.93e-05	0.000859	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1B—Graves' disease	6.82e-05	0.000847	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-A—Graves' disease	6.81e-05	0.000845	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-B—Graves' disease	6.66e-05	0.000827	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—Graves' disease	6.46e-05	0.000801	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-E—Graves' disease	6.25e-05	0.000776	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-DRB1—Graves' disease	6.22e-05	0.000772	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-A—Graves' disease	6.17e-05	0.000766	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GC—Graves' disease	6.17e-05	0.000765	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD40—Graves' disease	6.11e-05	0.000758	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CTLA4—Graves' disease	6.02e-05	0.000748	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—ICAM1—Graves' disease	5.97e-05	0.000741	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—B3GNT2—Graves' disease	5.89e-05	0.00073	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-E—Graves' disease	5.67e-05	0.000704	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-DRB1—Graves' disease	5.64e-05	0.0007	CbGpPWpGaD
Mesalazine—PTGS2—Disease—B3GNT2—Graves' disease	5.58e-05	0.000692	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD40—Graves' disease	5.54e-05	0.000688	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TSHR—Graves' disease	5.47e-05	0.000678	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CTLA4—Graves' disease	5.46e-05	0.000678	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—ICAM1—Graves' disease	5.41e-05	0.000672	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DQB1—Graves' disease	4.96e-05	0.000616	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TSHR—Graves' disease	4.96e-05	0.000615	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—B3GNT2—Graves' disease	4.67e-05	0.00058	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD8A—Graves' disease	4.63e-05	0.000575	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—Graves' disease	4.57e-05	0.000567	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DQB1—Graves' disease	4.5e-05	0.000558	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-B—Graves' disease	4.46e-05	0.000553	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	4.39e-05	0.000545	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—Graves' disease	4.39e-05	0.000544	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD8A—Graves' disease	4.2e-05	0.000521	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2RA—Graves' disease	4.18e-05	0.000518	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—Graves' disease	4.14e-05	0.000514	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-A—Graves' disease	4.13e-05	0.000512	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-B—Graves' disease	4.04e-05	0.000501	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—Graves' disease	3.98e-05	0.000494	CbGpPWpGaD
Mesalazine—CHUK—Disease—HLA-A—Graves' disease	3.81e-05	0.000473	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2RA—Graves' disease	3.79e-05	0.00047	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DRB1—Graves' disease	3.77e-05	0.000468	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-A—Graves' disease	3.74e-05	0.000465	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—Graves' disease	3.69e-05	0.000458	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ICAM1—Graves' disease	3.62e-05	0.000449	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL10—Graves' disease	3.53e-05	0.000438	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DRB1—Graves' disease	3.42e-05	0.000424	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ICAM1—Graves' disease	3.28e-05	0.000407	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL10—Graves' disease	3.2e-05	0.000397	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNG—Graves' disease	2.75e-05	0.000342	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2RA—Graves' disease	2.7e-05	0.000335	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—Graves' disease	2.66e-05	0.00033	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNG—Graves' disease	2.5e-05	0.00031	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—Graves' disease	2.46e-05	0.000305	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—Graves' disease	2.46e-05	0.000305	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2RA—Graves' disease	2.45e-05	0.000304	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—Graves' disease	2.41e-05	0.000299	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HLA-A—Graves' disease	2.26e-05	0.00028	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—Graves' disease	2.23e-05	0.000276	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—Graves' disease	1.46e-05	0.000181	CbGpPWpGaD
